UK markets closed

Shandong Xinhua Pharmaceutical Company Limited (XIN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.6300+0.0050 (+0.80%)
At close: 08:04AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 1.14B
Enterprise value 1.19B
Trailing P/E 6.84
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.42
Price/book (mrq)0.70
Enterprise value/revenue 0.15
Enterprise value/EBITDA 2.14

Trading information

Stock price history

Beta (5Y monthly) -0.01
52-week change 3-8.09%
S&P500 52-week change 322.38%
52-week high 30.7700
52-week low 30.5500
50-day moving average 30.6204
200-day moving average 30.6301

Share statistics

Avg vol (3-month) 3165
Avg vol (10-day) 3N/A
Shares outstanding 5195M
Implied shares outstanding 61.82B
Float 8407.19M
% held by insiders 110.68%
% held by institutions 11.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.03
Forward annual dividend yield 44.06%
Trailing annual dividend rate 30.25
Trailing annual dividend yield 340.00%
5-year average dividend yield 43.46
Payout ratio 428.53%
Dividend date 3N/A
Ex-dividend date 407 Jul 2023
Last split factor 213:10
Last split date 306 Jul 2018

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.13%
Operating margin (ttm)6.93%

Management effectiveness

Return on assets (ttm)3.67%
Return on equity (ttm)10.43%

Income statement

Revenue (ttm)7.94B
Revenue per share (ttm)11.70
Quarterly revenue growth (yoy)-6.30%
Gross profit (ttm)N/A
EBITDA 1B
Net income avi to common (ttm)486.79M
Diluted EPS (ttm)0.0900
Quarterly earnings growth (yoy)-6.40%

Balance sheet

Total cash (mrq)922.05M
Total cash per share (mrq)1.35
Total debt (mrq)1.32B
Total debt/equity (mrq)26.36%
Current ratio (mrq)1.42
Book value per share (mrq)6.98

Cash flow statement

Operating cash flow (ttm)487.09M
Levered free cash flow (ttm)320.7M